Novo CEO pressed by Senate to cut charges of obesity, diabetes medications CEO Lars Fruergaard Jørgensen advised lawmakers the company would look at new talks with insurers concerning the record costs of Wegovy and copyright should they pledge to keep the medicines on their formularies. Exactly where are every one https://kethek.com/